Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity (Q33332141)

25 July 2017

title

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity (English)

1 reference

25 July 2017

1 reference

Kahan BD

1

1 reference

25 July 2017

Napoli KL

2

1 reference

25 July 2017

Kelly PA

3

1 reference

25 July 2017

Podbielski J

4

1 reference

25 July 2017

Hussein I

5

1 reference

25 July 2017

Urbauer DL

6

1 reference

25 July 2017

Katz SH

7

1 reference

25 July 2017

Van Buren CT

8

1 reference

25 July 2017

publication date

1 April 2000

1 reference

25 July 2017

published in

Clinical Transplantation

1 reference

25 July 2017

volume

14

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

97-109

1 reference

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

Rapamycin: a novel immunosuppressive macrolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

Basic principles of ROC analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Therapeutic drug monitoring of tacrolimus in clinical transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Measurement of rapamycin in whole blood using reverse-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Determination of rapamycin in whole blood by HPLC

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Population pharmacokinetics of sirolimus in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Quantitative analysis of sirolimus (Rapamycin) in blood by high-performance liquid chromatography-electrospray tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

Simultaneous on-line extraction and analysis of sirolimus (rapamycin) and ciclosporin in blood by liquid chromatography-electrospray mass spectrometry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140201.X

7 January 2021

10.1034/J.1399-0012.2000.140201.X

Identifiers

DOI

1 reference

25 July 2017

1 reference